Invasive Therapies for Acute Coronary Syndromes in the COVID-19 Era
- 7 May 2021
- journal article
- review article
- Published by Springer Nature in Current Cardiology Reports
- Vol. 23 (6) , 1-9
Abstract
Purpose of Review To identify and address the challenges associated with the care of ACS patients during the coronavirus 2019 pandemic. Recent Findings The COVID-19 pandemic has had a considerable global impact with over 2.0 million deaths worldwide so far. There has been considerable evidence suggesting that COVID-19 increases the risk of acute coronary syndromes (ACS). Summary We propose characterizing ACS patients into 3 distinct categories to better assist in appropriate triage and management: critically ill patients, non-critically ill ST elevation myocardial infarction (STEMI) patients, and non-critically ill non-ST elevation myocardial infarction (NSTEMI)/unstable angina (UA) patients. We thoroughly review treatments strategies, management considerations, and current consensus statements for the care of COVID-19 patients with ACS. As we continue to gain more experience with management of COVID-19 in ACS patients and as health-care workers and patients continue to get vaccinated, we must continue to adapt our strategies to treat this high-risk group of patients.Keywords
This publication has 52 references indexed in Scilit:
- Fourth Universal Definition of Myocardial Infarction (2018)JACC, 2018
- Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysisInternational Journal of Infectious Diseases, 2016
- Part 10: Acute Coronary SyndromesCirculation, 2010
- The Strategic Reperfusion Early After Myocardial Infarction (STREAM) studyAmerican Heart Journal, 2010
- Long-Term Outcome of a Routine Versus Selective Invasive Strategy in Patients With Non–ST-Segment Elevation Acute Coronary SyndromeJACC, 2010
- Pathogen Recognition and Inflammatory Signaling in Innate Immune DefensesClinical Microbiology Reviews, 2009
- ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial InfarctionJACC, 2004
- Atypical presentations of SARSThe Lancet, 2003
- Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trialThe Lancet, 1999
- Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link?The Lancet, 1997